Back to Search
Start Over
A protective vaccine against the toxic activities following Brown spider accidents based on recombinant mutated phospholipases D as antigens
- Source :
- Scopus, Repositório Institucional da UNESP, Universidade Estadual Paulista (UNESP), instacron:UNESP
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- Made available in DSpace on 2022-05-01T09:47:17Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-12-01 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Universidade Federal do Paraná Fundação Araucária Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Accidents involving Brown spiders are reported throughout the world. In the venom, the major toxins involved in the deleterious effects are phospholipases D (PLDs). In this work, recombinant mutated phospholipases D from three endemic species medically relevant in South America (Loxosceles intermedia, L. laeta and L. gaucho) were tested as antigens in a vaccination protocol. In such isoforms, key amino acid residues involved in catalysis, magnesium-ion coordination, and binding to substrates were replaced by Alanine (H12A-H47A, E32A-D34A and W230A). These mutations eliminated the phospholipase activity and reduced the generation of skin necrosis and edema to residual levels. Molecular modeling of mutated isoforms indicated that the three-dimensional structures, topologies, and surface charges did not undergo significant changes. Mutated isoforms were recognized by sera against the crude venoms. Vaccination protocols in rabbits using mutated isoforms generated a serum that recognized the native PLDs of crude venoms and neutralized dermonecrosis and edema induced by L. intermedia venom. Vaccination of mice prevented the lethal effects of L. intermedia crude venom. Furthermore, vaccination of rabbits prevented the cutaneous lesion triggered by the three venoms. These results indicate a great potential for mutated recombinant PLDs to be employed as antigens in developing protective vaccines for Loxoscelism. Department of Cell Biology Federal University of Paraná (UFPR) Production and Research Center of Immunobiological Products (CPPI) State Department of Health Veterinary Hospital Federal University of Paraná (UFPR) Department of Structural Molecular Biology and Genetics State University of Ponta Grossa (UEPG) Multiuser Center for Biomolecular Innovation Departament of Physics Universidade Estadual Paulista (UNESP) Multiuser Center for Biomolecular Innovation Departament of Physics Universidade Estadual Paulista (UNESP) Universidade Federal do Paraná: 02/2020 Universidade Federal do Paraná: 04/2019 Fundação Araucária: 057/2017 CNPq: 303868/2016-3 CNPq: 408633/2018-2
- Subjects :
- Models, Molecular
Gene isoform
Necrosis
Brown spider
Spider Venoms
Venom
Phospholipase
Biology
Biochemistry
Microbiology
law.invention
Leukocyte Count
Mice
Structure-Activity Relationship
Immunogenicity, Vaccine
Antigen
Neutralization Tests
Structural Biology
law
Brown Recluse Spider
Spider Bites
Phospholipase D
medicine
Animals
Molecular Biology
Loxoscelism
Vaccines
Antivenins
Vaccination
General Medicine
Mutated phospholipases D
medicine.disease
Antibodies, Neutralizing
Disease Models, Animal
Treatment Outcome
Accidents
Recombinant DNA
Mutant Proteins
Rabbits
medicine.symptom
Biomarkers
Subjects
Details
- ISSN :
- 01418130
- Volume :
- 192
- Database :
- OpenAIRE
- Journal :
- International Journal of Biological Macromolecules
- Accession number :
- edsair.doi.dedup.....8ae04a7fc0397ed0ae44e1b87499b505
- Full Text :
- https://doi.org/10.1016/j.ijbiomac.2021.10.005